BLS Pharmaceuticals LimitedASX: BLS

BLS Pharmaceuticals: Notice of Annual General Meeting/Proxy Form

· Issued by BLS Pharmaceuticals Limited via ASX

Filed with ASX · · 43 pages · English

Summary by 6ix AI

The meeting is scheduled to take place at a specified location in Sydney, and shareholders are encouraged to vote by proxy if they cannot attend in person. Key resolutions include the adoption of the remuneration report, re-election of directors, and approval of an equity incentive plan. The document also outlines voting procedures and restrictions for certain resolutions, ensuring compliance with corporate governance standards.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

BLS PHARMACEUTICALS LIMITED (formerly Bioxyne Limited) ACN 084 464 193 NOTICE OF ANNUAL GENERAL MEETING Explanatory Memorandum and Proxy Form Time: 4:00pm AEDT Date: 24 November 2026 To be held at Addisons, Level 10, 2 Park Street Sydney NSW 2000 This Notice of Annual General Meeting and...

BLS Pharmaceuticals Limited on 6ix

Earlier from BLS Pharmaceuticals

Later from BLS Pharmaceuticals

All BLS Pharmaceuticals news releases